SS Innovations International, Inc. (Nasdaq: SSII) has announced that its flagship SSi Mantra surgical robotic system received official approval for telesurgeries in Indonesia and the Philippines. This regulatory milestone marks a significant step in the company's strategic expansion across the growing Southeast Asian markets. Additionally, the company reported surpassing the milestone of 150 cumulative successful telesurgeries performed globally using the SSi Mantra system. SS Innovations remains focused on providing affordable and accessible robotic surgical solutions to address global healthcare needs. These approvals are expected to strengthen the company's market position within the medical technology sector and drive future revenue growth. Investors view this expansion as a positive catalyst for the firm's long-term clinical track record and geographic reach.
Sign up free to access this content
Create Free Account